Viking Therapeutics, Inc. Shares Outstanding (Cover Page)
Viking Therapeutics, Inc. (VKTX) had Shares Outstanding (Cover Page) of 116.65 million shares as of 2026-07-15, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-29
- 2026-07-15: Entity Common Stock, Shares Outstanding 116.65M shares.
- 2026-04-15: Entity Common Stock, Shares Outstanding 116.11M shares.
- 2026-01-31: Entity Common Stock, Shares Outstanding 115.55M shares.
- 2025-10-15: Entity Common Stock, Shares Outstanding 113.04M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-15 | 116.65M shares 10-Q · filed 2026-07-29 |
| 2026-04-15 | 116.11M shares 10-Q · filed 2026-04-30 |
| 2026-01-31 | 115.55M shares 10-K · filed 2026-02-11 |
| 2025-10-15 | 113.04M shares 10-Q · filed 2025-10-23 |
| 2025-07-15 | 112.44M shares 10-Q · filed 2025-07-23 |
| 2025-04-15 | 112.31M shares 10-Q · filed 2025-04-24 |
| 2025-01-31 | 112.25M shares 10-K · filed 2025-02-26 |
| 2024-10-15 | 111.44M shares 10-Q · filed 2024-10-23 |
| 2024-07-15 | 110.80M shares 10-Q · filed 2024-07-24 |
| 2024-04-15 | 110.27M shares 10-Q · filed 2024-04-25 |
| 2024-01-31 | 100.49M shares 10-K · filed 2024-02-07 |
| 2023-10-15 | 100.03M shares 10-Q · filed 2023-10-25 |
| 2023-07-15 | 100.03M shares 10-Q · filed 2023-07-26 |
| 2023-04-15 | 99.58M shares 10-Q · filed 2023-04-26 |
| 2023-01-31 | 78.42M shares 10-K · filed 2023-02-10 |
| 2022-10-15 | 76.69M shares 10-Q · filed 2022-10-26 |
| 2022-07-15 | 76.69M shares 10-Q · filed 2022-07-27 |
| 2022-04-15 | 77.37M shares 10-Q · filed 2022-04-27 |
| 2022-01-31 | 78.36M shares 10-K · filed 2022-02-09 |
| 2021-10-15 | 78.23M shares 10-Q · filed 2021-11-03 |
| 2021-07-15 | 78.19M shares 10-Q · filed 2021-07-28 |
| 2021-04-15 | 78.10M shares 10-Q · filed 2021-04-28 |
| 2021-01-31 | 74.13M shares 10-K · filed 2021-02-17 |
| 2020-10-15 | 72.95M shares 10-Q · filed 2020-10-28 |
| 2020-07-15 | 72.76M shares 10-Q · filed 2020-07-29 |
| 2020-04-15 | 72.60M shares 10-Q · filed 2020-04-30 |
| 2020-01-31 | 72.56M shares 10-K · filed 2020-02-26 |
| 2019-10-31 | 72.26M shares 10-Q · filed 2019-11-05 |
| 2019-07-31 | 72.21M shares 10-Q · filed 2019-08-01 |
| 2019-04-30 | 72.05M shares 10-Q · filed 2019-05-02 |
| 2019-02-28 | 71.99M shares 10-K · filed 2019-03-13 |
| 2018-10-31 | 71.46M shares 10-Q · filed 2018-11-07 |
| 2018-07-31 | 60.66M shares 10-Q · filed 2018-08-09 |
| 2018-04-30 | 50.93M shares 10-Q · filed 2018-05-09 |
| 2018-02-28 | 50.90M shares 10-K · filed 2018-03-07 |
| 2017-10-31 | 28.50M shares 10-Q · filed 2017-11-08 |
| 2017-07-31 | 27.70M shares 10-Q · filed 2017-08-09 |
| 2017-04-30 | 23.93M shares 10-Q · filed 2017-05-10 |
| 2017-02-28 | 23.83M shares 10-K · filed 2017-03-21 |
| 2016-10-31 | 20.17M shares 10-Q · filed 2016-11-10 |
| 2016-07-31 | 19.28M shares 10-Q · filed 2016-08-11 |
| 2016-04-29 | 19.27M shares 10-Q · filed 2016-05-10 |
| 2016-02-29 | 9.68M shares 10-K · filed 2016-03-08 |
| 2015-11-02 | 9.68M shares 10-Q · filed 2015-11-05 |
| 2015-08-10 | 9.78M shares 10-Q · filed 2015-08-14 |
| 2015-06-10 | 9.78M shares 10-Q · filed 2015-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |